• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 36 of 100
You can now sign up to participate in COVID-19 vaccine clinical trials
HealthYou can now sign up to participate in COVID-19 vaccine clinical trials
By Jonathan VanianJuly 8, 2020
In the COVID-19 vaccine race, nobody wins unless everyone wins
CommentaryIn the COVID-19 vaccine race, nobody wins unless everyone wins
By Seth BerkleyJuly 8, 2020
A dose of good news: Pfizer shares surge on coronavirus vaccine trial
FinanceA dose of good news: Pfizer shares surge on coronavirus vaccine trial
By Rey MashayekhiJuly 1, 2020
Gilead remdesivir coronavirus FDA
HealthCOVID treatment remdesivir will cost $520 per vial. But it may not be how much you pay
By Sy MukherjeeJune 29, 2020
Gilead coronavirus treatment drug Remdesivir
HealthGilead to charge thousands for coronavirus treatment drug that critics say should cost $1
By Robert Langreth and BloombergJune 29, 2020
Gilead inhaled remdesivir trial
HealthGilead’s next COVID-19 treatment advancement could keep patients out of hospitals
By Sy MukherjeeJune 22, 2020
Court rules Trump can’t require drugmakers to disclose prices in TV ads
HealthCourt rules Trump can’t require drugmakers to disclose prices in TV ads
By The Associated PressJune 18, 2020
ADHD video game Akili FDA
HealthHow the first-ever digital ADHD treatment—a video game—got the FDA’s blessing
By Sy MukherjeeJune 17, 2020
Second wave coronavirus
NewslettersA second coronavirus wave isn’t imminent—the first one never ended
By Sy MukherjeeJune 11, 2020
AstraZeneca Gilead deal
HealthRumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By Sy MukherjeeJune 8, 2020
5 companies to keep an eye on following the world’s largest cancer conference
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
FinanceFrance’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By James Paton, Riley Griffin and BloombergMay 26, 2020
Hydroxychloroquine study shows deaths, heart risks in COVID-19 patients
HealthHydroxychloroquine linked to deaths and heart risks in new COVID-19 study after Trump touted and claimed to be taking the drug
By John Lauerman and BloombergMay 22, 2020
Moderna Therapeutics coronavirus vaccine
NewslettersModerna’s coronavirus vaccine expectations game
By Sy MukherjeeMay 21, 2020
Tobacco giants are getting into the coronavirus vaccine race
HealthTobacco giants are getting into the coronavirus vaccine race
By Sy MukherjeeMay 21, 2020
1...
  • 34
  • 35
  • 36
  • 37
  • 38
...100
Most Popular
Real Estate
Gen Z fled San Francisco for Texas and Florida. Now they’re turning ‘welcomer cities’ into the next big tech townsplaceholder alt text
By Sydney LakeJune 13, 2026
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Middle East
Trump expects to sign a deal with Iran on Sunday, but Tehran may want to avoid giving him a gift on his birthdayplaceholder alt text
By Jason MaJune 13, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.